Implementing a National Cancer Clinical Trials System for the 21st Century: A Workshop

Workshop

Implementing a National Cancer Clinical Trials System for the 21st Century: Follow Up Workshop

February 11 - 12, 2013

Past

Materials

About

This workshop was co-sponsored by the Institute of Medicine and the American Society of Clinical Oncology (ASCO).

This workshop examined ongoing activities in the implementation of the recommendations put forth in the IOM consensus report, A National Cancer Clinical Trials System for the 21st Century. This was the second part to a two-part workshop series. The first workshop was held in early 2011 and invited all stakeholders charged with making changes to the system to discuss what changes they planned to implement in response to the IOM recommendations. This follow-up workshop reconvened these key stakeholders to discuss progress made to date and to identify additional actions to take. Workshop sessions and discussions highlighted progress made by NCI and the Clinical Trials Network, funding needs and opportunities, strategies for prioritizing trial concepts, ongoing and future implementation challenges, opportunities for the development of effective partnerships to accelerate innovation, and current regulatory issues.
PLANNING COMMITTEE:
Monica M. Bertagnolli (chair), Alliance for Clinical Trials In Oncology and Dana-Farber Cancer Institute
Amy P. Abernethy, Duke University School of Medicine
Michael A. Caligiuri, Comprehensive Cancer Center at the Ohio State University
Renzo Canetta, Bristol-Myers Squibb Company
Michaele Chamblee Christian, retired
James H. Doroshow, NCI
Patrick Gavin, Patrick Gavin R.Ph. Consulting LLC
Gregory H. Reaman, FDA
George W. Sledge, Jr., Indiana University Simone Cancer Center
Ralph R. Weichselbaum, The University of Chicago Medical Center
Robin Zon, Northern Indiana Cancer Research Consortium CCOP
SPEAKERS, MODERATORS AND PANELISTS:
Jeffrey Abrams, CTEP and NCI Division of Cancer Treatment and Diagnosis
Peter Adamson, Children's Oncology Group
Margaret Anderson, FasterCures
Edward Benz, Dana-Farber Cancer Institute
Charles Blanke, SWOG and OHSU Knight Cancer Institute
Renzo Canetta, Bristol-Myers Squibb
Renaud Capdeville, Novartis Oncology
Robert Comis, ECOG-ACRIN Cancer Research Group
Barbara Conley, NCI
Walter Curran, NRG Oncology Group and Emory Winship Cancer Institute
Robert Diasio, Mayo Clinic Cancer Center
Joseph DiMasi, Tufts Center for the Study of Drug Development
Lori Dodd, NCI Biostatistics Research Branch
James H. Doroshow, NCI Division of Cancer Treatment and Diagnosis
Hans-Georg Eichler, European Medicines Agency, NEWDIGS Initiative, MIT Center for Biomedical Innovation
Levi Garraway, Dana-Farber Cancer Institute
Patrick Gavin, Patrick Gavin R.Ph. Consulting LLC
Stephen Grubbs, Helen F. Graham Cancer Center and Christiana Care CCOP
Sandra Horning, Genentech
Robert Iannone, Merck Research Laboratories
Richard Kaplan, UK National Cancer Research Network and Medical Research Council
Worta McCaskill-Stevens, NCI Division of Cancer Treatment and Diagnosis
Lisa McShane, NCI Division of Cancer Treatment and Diagnosis
John Mendelsohn, MD Anderson Cancer Center
Vincent Miller, Foundation Medicine
Richard Pazdur, FDA Office of Hematology and Oncology Products
Francesco Pignatti, European Medicines Agency
Nancy Roach, Fight Colorectal Cancer
Debasish Roychowdhury, Sanofi Oncology
Marc Sabatine, Thrombolysis in Myocardial Infarction (TIMI) Study Group
Richard Schilsky, American Society of Clinical Oncology
Rachel Sherman, FDA Office of Medical Policy
George W. Sledge, Jr., Stanford University School of Medicine
David Solit, Memorial Sloan-Kettering Cancer Center
Robin Zon, Michiana Hematology Oncology, PC and Northern Indiana Cancer Research Consortium CCOP

To watch the recording of this workshop, visit: February 2013 - Implementing a National Cancer Clinical Trials System for the 21st Century

Contact

Katherine Hawthorne

(202) 334-1453
khawthorne@nas.edu

Location

Keck Center

500 5th St NW

Washington DC 20001, USA

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Log In

Sign in to access your saved publications, downloads, and email preferences.

Former MyNAP users: You'll need to reset your password on your first login to MyAcademies. Click "Forgot password" below to receive a reset link via email. Having trouble? Visit our FAQ page to contact support.

Members of the National Academy of Sciences, National Academy of Engineering, or National Academy of Medicine should log in through their respective Academy portals.

Email (required)
Password (required)

Don't have an account?

Register

Email (required)
New password (required)
Retype password (required) Password must be at least 8 characters
I accept the terms of use
terms of use

Thank You

Thank you for creating a MyAcademies account!

Enjoy free access to thousands of National Academies' publications, a 10% discount off every purchase, and build your personal library.

Forgot Password

Enter the email address for your MyAcademies (formerly MyNAP) account to receive password reset instructions.

Reset Requested

We sent password reset instructions to your email . Follow the link in that email to create a new password. Didn't receive it? Check your spam folder or contact us for assistance.

Reset Password

New password (required)
Retype password (required) Password must be at least 8 characters

Reset Password

Your password has been reset.

Log In

Verify email

Verify Your Email Address

We sent a verification link to your email. Please check your inbox (and spam folder) and follow the link to verify your email address. If you did not receive the email, you can request a new verification link below

Subscribe

First Name
Last Name
Email (required)
I agree to receive emails from the National Academies (required)

We respect your privacy and will never share your information.

My Academies

Implementing a National Cancer Clinical Trials System for the 21st Century: A Workshop

Dropdown items

Implementing a National Cancer Clinical Trials System for the 21st Century: Follow Up Workshop

Implementing a National Cancer Clinical Trials System for the 21st Century